On Jan. 07, Ortenzio Robert A divested U.S. $8,734,349 in shares of Select Medical Holdings Corporation. The Exec. COB, Co-Founder sold 281,578 shares at a price per share of $31.02. The transaction decreased this specific insider’s holdings to 13,873,363 shares worth around $424.39 million at present.
BofA/Merrill took its Select Medical Holdings Corporation [SEM] rating to the equivalent of an Underperform from a Neutral, and the price target to $15 from $18, in a research note dated June 16, 2020. That figure represents around a -103.93% premium from where the company’s shares closed on Friday. Other analysts also revised their coverage, with BofA/Merrill’s analysts downgrading the shares from “a Neutral” rating to “an Underperform” rating in a research note to investors issued in mid June. Meanwhile, Deutsche Bank had launched its coverage on SEM with “Buy”, in a research note produced for clients September 17, 2019. In addition, there was an upgrade from JMP Securities on May 17, 2019. The rater changed SEM from “a Mkt perform” to “a Mkt outperform”.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Is Select Medical Holdings Corporation [NYSE:SEM] a Good Buy Right Now?
It should be noted that SEM technical indicators for short, intermediate as well as long term progress have placed an overall average of 100% as Buy. The average signal changed from 100% Buy in the last week and compares with 100% Buy in the past month. Data from Select Medical Holdings Corporation’s Trend Spotter indicated that the signals were Weakening. The stock current average is 0.51 million shares in the past 20 days and the short term average signal indicates a 100% Buy. In the last 50 days, the average trading volume was 0.51 million shares while the medium term average advocated for 100% Buy. The average long-term signal stands at 100% Buy and the 100-day average volume stands at 0.5 million shares.
SEM Price Performance
On Wall Street, Select Medical Holdings Corporation [NYSE:SEM] finished Friday’s session down -0.75% at $30.59. The stock went up to $31.30 at the same session while its lowest single day price was $29.93. In the last five days, it saw a rise of about 10.59%, Select Medical Holdings Corporation shares gained by almost 10.59% since the beginning of the year. However, the share price has dropped to as low as -1.32% below its one year high. On 01/08/21, the company shares recorded $31.30, the highest single-day price it has got to in the last 52-weeks and a 52-week low was seen on 01/04/21, the same year at $27.05. The company’s shares have inclined by 32.54% in the past year. The 50-day SMA achieved is $25.51 while the 200-day SMA is $19.50. Volume gained to 1.16 million from 0.53 million in the previous session.
Select Medical Holdings Corporation [SEM] Valuation Measures
Notably, Select Medical Holdings Corporation [SEM] stock can be classified as a good candidate in the listing of underestimated low-priced Medical Care Facilities companies to purchase soonest possible with the prevailing 12-month PE ratio of 19.23. The measure means the stock is exchanging at a discount as compared to the 30.86x trailing earnings of the industry. It can be helpful for investors to consider historical price-sales ratio, more specifically, a 0.76 PS value ratio is reported for the last one year of reported earnings. That is lower than the industry average of 2.26 which means SEM serve an attractive investment opportunity compared to its competitors.
SEM Stock Support And Resistance Levels
On the 24-hour scale, the immediate backing is perceived around 29.91 level, and in case of violation of this particular level, it will cause more drop to 29.24 level. On the upper level, 31.98 is still the key resistance. The stock may increase to the subsequent resistance at 31.28. The Relative Strength Index (RSI) pinned on the 14-day chart is 77.29, implying a overbought technical stance while the MACD stands at 2.55, meaning price will increase in the next trading period. Percent R indicator moved to 12.54%, implying bullish price movement. Stochastic %K at 90.25% suggest selling the stock.
What is the short interest in Select Medical Holdings Corporation?
Short interest in the Select Medical Holdings Corporation stock has plunged, decreasing by -0.13 million shares to total 2.37 million shares on Dec 14, 2020. The interest had seen shares on Nov 12, 2020 stand at 2.24 million, data from Yahoo Finance shows. The increase of 5.49% suggests the stock saw some increased bearish sentiment. The stock’s days to cover (short ratio) moved to while the shorted shares account for just 3.45% of the overall float for the stock.
Select Medical Holdings Corporation’s Biggest Shareholders: Who Owns Select Medical Holdings Corporation [SEM]?
Filings by T. Rowe Price Associates, Inc. showed that the firm now holds a total of 21,957,600 shares or roughly 16.29% of the outstanding SEM shares. This means their shares have increased by 1,430 from the 21,957,600 the investor reportedly held in its prior 13-F filing. With the conclusion of the purchase, BlackRock Fund Advisors updated stake is worth $365,583,046. Details in the latest 13F filings reveal that The Vanguard Group, Inc. disposed off their -2.40% stake valued at $269,885,127 while Dimensional Fund Advisors LP cut theirs at $140,941,813. During the last quarter, The Vanguard Group, Inc. liquidated -275,248 of its shares in Select Medical Holdings Corporation while Dimensional Fund Advisors LP sold -84,126 shares. The LSV Asset Management’s holdings currently number 4,274,651 shares at $130761574.09. According to the firm’s last 13F report, SSgA Funds Management, Inc. shares in the company at filing stood at 3,490,322 shares, roughly $84,116,760.
SEM Earnings Forecast For The Current Quarter
Select Medical Holdings Corporation [SEM] is expected to report strong earnings results for the quarter ending on Dec 2020. Consensus estimates give the company expected revenues of $1.41B and an earnings per share of $0.31 for Dec 2020. Looking further ahead, the company is expected to report revenue of $1.43B at an EPS of $0.39 for Mar 2021. The estimates represent upside of 6.50% and 1.36% in the company’s revenue and earnings per share, respectively, on a year-on-year basis.
SEM Earnings Estimates For The Current Year
For the financial year, Select Medical Holdings Corporation [NYSE:SEM] is expected to bring in revenue of $5.48B. The returns are nearly $30.0 million higher than the company’s actual revenue recorded in the fiscal year 2019. In terms of EPS for the 2020, estimate put it at 1.62, higher than that of FY19 by $0.38. Estimates put this year’s earnings growth at 30.60%, 1.20% for the next, and at an annual 18.50% over the next 5-year period. As for sales, forecasts are for an increase of 0.50% in the current fiscal year and a further 6.50% over the following year.
What are analyst thoughts on Select Medical Holdings Corporation?
Looking forward to the Select Medical Holdings Corporation share price prediction, we can see that analysts, surveyed by FactSet, offer the mean price target for Select Medical Holdings Corporation stock at $31.00 within the next 12 months, which represents almost 1.32 per cent growth from its previous closing price of $30.59. The highest analysts’ target for Select Medical Holdings Corporation stock projections is $33.00 and the lowest one is $27.00. Still, 5 analysts sharing their consensus rating for SEM stock in 2021 agree that it is an Overweight.